Arrowhead Research ARWR Current ratio

Current ratio at other companies

Ionis PharmaceuticalsIONS

7.9×+5.0×

ALN

Alnylam PharmaceuticalsALNY

3.1×+0.3×

Assembly BiosciencesASMB

6.6×+4.6×

Arbutus Biopharma CorporationABUS

54.3×+48.3×

Ultragenyx PharmaceuticalRARE

1.7×-0.7×

Beam TherapeuticsBEAM

17×+8.2×

FAQ

What is Arrowhead Research's current ratio?

Arrowhead Research (ARWR) reported current ratio of 6.2× in Q1 2026.

How has Arrowhead Research's current ratio changed year-over-year?

Arrowhead Research's current ratio increased by 21.1% year-over-year, from 5.1× to 6.2×.

What is the long-term trend for Arrowhead Research's current ratio?

Over 4 years (2021 to 2025), Arrowhead Research's current ratio has grown at a 16.7% compound annual growth rate (CAGR), from 2.6× to 4.9×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.